Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Find various ways to profit from your skills and maximize your earning potential. Start turning your abilities into cash now!
17,603 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
As 1stdibs gears up for 2025 earnings, investors crave clarity on growth, profitability, and sustainable margins. Thi...
As investors eye pagseguro (pags) 2026 earnings, this guide breaks down what to watch, how growth could unfold, and p...
MercadoLibre faced a sharp price move after a quarter that showed strong top-line momentum but weaker profitability. ...
Today’s rally in a leading off-price retailer highlights how earnings, margins, and guidance can move a stock. This a...
MongoDB stock is under pressure again, with shares dropping sharply amid a broad market sell-off. This article breaks...
This article breaks down what the stock market today is telling investors about NIO and the EV sector. Learn how reve...
February was brutal for some software names. This piece breaks down why monday.com stock lost february, what that sig...
As AI accelerates,Microsoft's split with OPENAI could reshape strategy and investor returns. Learn what this means fo...
Nebius Group stock charged higher on Wednesday amid fresh AI cloud developments. This article breaks down the catalys...
Hormel Foods is seeing a noteworthy rally after beating on earnings and reaffirming guidance. This article breaks dow...